Stock Research: Syngene International

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Syngene International

BSE:539268 INE398R01022
1
  • Value
    57
  • Growth
    29
  • Safety
    Safety
    21
  • Combined
    8
  • Sentiment
    17
  • 360° View
    360° View
    1
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Syngene International Limited is an India-based integrated research, development, and manufacturing services company. It serves the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors with services including discovery, development, manufacturing, and integrated drug discovery platforms. In the last fiscal year, the company had a market cap of $3121 million, profits of $308 million, revenue of $426 million, and 6533 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 1 (better than 1% compared with alternatives), overall professional sentiment and financial characteristics for the stock Syngene International are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Syngene International. The only rank that is above average is the consolidated Safety Rank at 57, which means that the company has a financing structure that is safer than those of 57% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 21, which means that the share price of Syngene International is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 29, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 17, which means that professional investors are more pessimistic about the stock than for 83% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 13 10 3
Growth
29 49 43 47
Safety
Safety
57 56 67 49
Sentiment
17 5 27 56
360° View
360° View
1 4 10 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
39 29 46 3
Opinions Change
67 15 50 30
Pro Holdings
n/a 16 35 100
Market Pulse
38 34 53 69
Sentiment
17 5 27 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 13 10 3
Growth
29 49 43 47
Safety Safety
57 56 67 49
Combined
8 14 23 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
13 15 12 9
Price vs. Earnings (P/E)
32 25 22 9
Price vs. Book (P/B)
28 28 28 19
Dividend Yield
20 14 15 17
Value
21 13 10 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 85 96 80
Profit Growth
14 12 46 38
Capital Growth
55 85 9 21
Stock Returns
17 37 49 49
Growth
29 49 43 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
61 62 58 50
Refinancing
34 27 39 35
Liquidity
54 57 64 56
Safety Safety
57 56 67 49

Similar Stocks

Discover high‑ranked alternatives to Syngene International and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

NMDC

BSE:526371
Country: India
Industry: Steel
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.